Navion Neurosciences
Our MissionOur FocusOur ApproachTeamNewsContact

Navion Neurosciences Closes $10.8 Million Seed Financing to Advance Precision Sodium-Channel Medicines for Epilepsy and Neuropathic Pain

Navion announces a $10.8 million seed financing first closing to advance genetic epilepsy and chronic neuropathic pain programs and expand its AI-enabled NaViGATion™ discovery platform.

We’re navigating a pathtoward a better tomorrow.

To the patients and families facing seizures and chronic pain every day:we see you, we hear you, and we are working for you.

You inspire our mission. You fuel our progress. You are our why.
Navion Neurosciences

Navion Neurosciences is a pre-clinical biopharmaceutical company developing precision sodium channel therapeutics for serious neurological disorders.

Contact: Info@Navionneuro.com

ContactPrivacy Policy
© 2026 Navion Neurosciences, Inc.